Clinical Trial Update: Aldosterone Antagonism and Microvascular Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on aldosterone antagonism evaluating microvascular function in abdominal obesity/metabolic syndrome with insulin resistance; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Obesity
• Hypertension
• Insulin Resistance
• Metabolic Syndrome

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Abdominal Obesity Metabolic Syndrome, Insulin Resistance | Phase 4 | Status: TERMINATED